{"id":46,"date":"2022-10-26T12:31:49","date_gmt":"2022-10-26T09:31:49","guid":{"rendered":"https:\/\/conf.icgbio.ru\/lymphology2023\/?page_id=46"},"modified":"2023-03-10T11:24:28","modified_gmt":"2023-03-10T08:24:28","slug":"thesis-2","status":"publish","type":"page","link":"https:\/\/conf.icgbio.ru\/lymphology2023\/thesis-2\/","title":{"rendered":"Abstract submission requirements"},"content":{"rendered":"

Abstract language: Russian or English.<\/span>
\nAbstract volume: up to 2 typewritten pages<\/span>
\nFont: 12 Times New Roman.<\/span>
\nLine spacing is single.
\nMargins: top — 20 mm, bottom — 20 mm, left — 25 mm, right — 15 mm.
\nParagraph indentation — 1.25 cm. For characters that are not in the main font, use only the Symbol font.<\/span>
\nAbstracts should not contain figures, graphs, diagrams and other illustrations. In the text of the abstracts, it is not allowed to mention the commercial names of drugs.<\/span><\/p>\n

EXAMPLE of the design of abstract<\/u><\/strong><\/span><\/p>\n

TITLE<\/span>
\nspace
\n<\/em><\/strong>Surname Initials<\/span>
\nOrganization, city, country (in italics)
\n<\/em>E-mail of the presenting author.<\/span><\/p>\n

On the first line in the center in capital letters the title of the work.<\/span>
\nBelow in the center — in lowercase letters the surname and initials of the author (authors). An asterisk should indicate the presenting author.<\/span>
\nOn the next line, in the center — the abbreviated name of the organization, city, country.<\/span>
\nE-mail address. If the work comes from several organizations, you should indicate affiliation in numbers.<\/span><\/p>\n

EXAMPLE of abstracts:<\/u><\/strong><\/span><\/p>\n

MORPHOLOGY OF THE CONNECTIVE TISSUE MATRIX AND THE LYMPHATIC BED OF THE EXTERNAL GENITAL ORGANS IN PRIMARY LYMPHEDEMA<\/span>
\nempty line
\n<\/em><\/strong>1<\/sup>Inyoshina A.D., 2<\/sup>Savchenko S.V., 1<\/sup>Bgatova N.P., 1<\/sup>Soluyanov M.Yu., 1<\/sup> Nimaev V.V.*<\/span>
\n1<\/sup><\/em>NIIKEL-branch of ICG SB RAS, Novosibirsk, Russia; 2<\/sup>Novosibirsk State Medical University, Russia
\n<\/em>nimaev@gmail.com<\/span>
\nempty line<\/em><\/strong><\/span><\/p>\n

Introduction:<\/strong> the relevance and novelty of the study are briefly substantiated. Volume — up to \u00bd page.<\/span>
\nObjective:
\n<\/strong>Materials and methods<\/strong>: the design of the study, the characteristics of the sample, the methods used, including the types of statistical analysis, are indicated.<\/span>
\nResults and discussion:<\/strong> specific scientific data are presented, supported by the results of statistical analysis.<\/span>
\nConclusions:<\/strong> conclusions and recommendations are concisely formulated, corresponding to the purpose of the study.<\/span>
\nReference<\/strong>: no more than 5 sources. For each, indicate: author(s), title, full imprint, doi (if available).<\/span>
\nKey words:<\/strong> from 3 to 7, separated from each other by a semicolon.<\/span>
\nAdditional information: information about financial (grant) support, gratitude, etc. This section can be omitted.<\/span><\/p>\n

 <\/p>\n

EXAMPLE of the design of cited sources:<\/u><\/strong><\/span><\/p>\n

\u00a0 \u00a0 \u00a0Korbut A.I., Klimontov V.V. Incretin-based therapy: renal effects. Diabetes. 2016; 19(1):53-63. doi:14341\/DM7727.<\/span>
\n\u00a0 \u00a0 \u00a0Ovsyannikova A.K., Rymar O.D., Shakhtshneider E.V., Klimontov V.V., Koroleva E.A., Myakina N.E., Voevoda M.I. ABCC8-Related maturity-onset diabetes of the young (MODY12): clinical features and treatment perspective. Diabetes Ther. 2016; 7(3): 591-600. doi: 10.1007\/s13300-016-0192-9.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

Abstract language: Russian or English. Abstract volume: up to 2 typewritten pages Font: 12 Times New Roman. Line spacing is… <\/p>\n","protected":false},"author":454,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/conf.icgbio.ru\/lymphology2023\/wp-json\/wp\/v2\/pages\/46"}],"collection":[{"href":"https:\/\/conf.icgbio.ru\/lymphology2023\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/conf.icgbio.ru\/lymphology2023\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/conf.icgbio.ru\/lymphology2023\/wp-json\/wp\/v2\/users\/454"}],"replies":[{"embeddable":true,"href":"https:\/\/conf.icgbio.ru\/lymphology2023\/wp-json\/wp\/v2\/comments?post=46"}],"version-history":[{"count":0,"href":"https:\/\/conf.icgbio.ru\/lymphology2023\/wp-json\/wp\/v2\/pages\/46\/revisions"}],"wp:attachment":[{"href":"https:\/\/conf.icgbio.ru\/lymphology2023\/wp-json\/wp\/v2\/media?parent=46"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}